This Week in NEJM

Premium

In NEJM this week, a team of researchers in Scandinavia and the US report results from a three-year follow-up of a study comparing the effectiveness of radical prostatectomies versus watching and waiting in early prostate cancer patients. From October 1989 to February 1999, the researchers randomly assigned 695 men with early prostate cancer to "watchful waiting" or radical prostatectomy, and continued to follow-up through December 2009.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Vox reports on inequities in genetic research and efforts to address them.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.